HRMY
Harmony Biosciences Holdings, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Harmony Biosciences Holdings, Inc.
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last report0 of 7 at or beyond impliedshaded = implied▲▼ = realized× = |realized| ÷ implied
Harmony Biosciences Holdings, Inc.
38.73
No thesis.
+8.93%
vs ±14.3% implied · ×0.62
shaded = implied · ▲▼ = realized
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | BlackRockBlackRockindex-like | $258.6M | 13.02% | +0.45% | |
| 2 | FMRFMR | $130.1M | 6.55% | +13.19% | |
| 3 | Vanguard Portfolio ManagementVanguard Portfolioindex-like | $104.9M | 5.28% | +6.12% | |
| 4 | American Century CompaniesAmerican Century Companies | $92.5M | 4.66% | +20.63% | |
| 5 | Dimensional Fund AdvisorsDimensional | $87.1M | 4.39% | +15.27% | |
| 6 | Vanguard Capital ManagementVanguardindex-like | $76.6M | 3.86% | +0.13% | |
| 7 | LSV Asset ManagementLSV | $75.0M | 3.78% | +1.78% | |
| 8 | State StreetState Streetindex-like | $67.7M | 3.41% | +4.20% | |
| 9 | Armistice CapitalArmistice Capital | $56.9M | 2.87% | −3.69% | |
| 10 | Geode Capital ManagementGeodeindex-like | $52.5M | 2.65% | +9.07% | |
| 11 | Arrowstreet Capital, Limited PartnershipArrowstreet Capital, Limited Partnership | $47.8M | 2.41% | −5.03% | |
| 12 | Renaissance TechnologiesRenaissance Technologies | $43.5M | 2.19% | +10.95% | |
| 13 | Two Sigma InvestmentsTwo Sigma | $34.9M | 1.76% | +30.77% | |
| 14 | AQR Capital ManagementAQR | $34.0M | 1.71% | +30.45% | |
| 15 | SG Americas SecuritiesSG Americas Securities | $32.1M | 1.62% | −56.26% | |
| 16 | Valor ManagementValor | $29.8M | 1.50% | +598.38% | |
| 17 | Morgan StanleyMorgan Stanley | $26.7M | 1.35% | −28.84% | |
| 18 | UBS GroupUBS | $22.0M | 1.11% | +34.60% | |
| 19 | DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am MainDZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | $20.1M | 1.01% | −2.83% | |
| 20 | InvescoInvesco | $19.2M | 0.97% | new | |
| 21 | JPMorgan ChaseJPMorgan Chase | $18.2M | 0.92% | new | |
| 22 | venBio PartnersvenBio Partners | $17.2M | 0.87% | −3.48% | |
| 23 | Northern TrustNorthern Trustindex-like | $17.2M | 0.86% | +11.34% | |
| 24 | BNP Paribas ArbitrageBNP Paribas Arbitrage | $16.0M | 0.80% | −19.61% | |
| 25 | Charles Schwab Investment ManagementCharles Schwabindex-like | $15.4M | 0.78% | +2.97% |
323 managers report $2.0B of Harmony Biosciences on form 13F for the quarter ended Jun 30 '26. 42 of them hold 80% of it; BlackRock is largest at 13.02%.
Expected move
Inputs8Q avg ±5.0%·×0.56·cheap
straddle ±10.6%
spot 38.76exp Nov 20ATM strike 40ATM straddle 4.85IV 63%